FStar Therapeutics Inc
Biotechnology
Healthcare
FSTX
21.86 M shares
NASDAQ US
traded
08 Mar 2023
listed
yes
open
7.11
52 week high
7.12
high
7.12
52 week low
2.18
previous Close
7.12
P/E ratio
market cap
157 M
div yield
0
net incoming
-18.41 M
3.09 %
net profit margin
-1636.18 %
-1636.00 %
operating incoming
-13.71 M
15.30 %
net change in cash
-17.40 M
-9.83 %
cash on hand
35.57 M
-32.84 %
top